Sangamo Therapeutics (SGMO) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.14
-0.09
-0.05
-0

Details

Expected EPS
-0.00045
Actual EPS
-0.11
Surprise EPS
-0.11
Surprise Percent
-24,344.44%

Description

⁨Sangamo Therapeutics⁩ (⁦SGMO⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts